Safety & Efficacy of a Single Dose of Sumatriptan Powder Delivered Intranasally With the Bi-directional Device in Adults With Acute Migraine
Clinical trial NCT01462812 · COMPLETED
Trial details
- NCT number
- NCT01462812
- Sponsor
- Optinose US Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2012-06-01
- Enrollment
- 223
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.